nodes	percent_of_prediction	percent_of_DWPC	metapath
Gadoversetamide—Asthenia—Vemurafenib—melanoma	0.00279	0.00279	CcSEcCtD
Gadoversetamide—Hallucination—Temozolomide—melanoma	0.00278	0.00278	CcSEcCtD
Gadoversetamide—Hypoaesthesia—Temozolomide—melanoma	0.00278	0.00278	CcSEcCtD
Gadoversetamide—Pharyngitis—Temozolomide—melanoma	0.00277	0.00277	CcSEcCtD
Gadoversetamide—Chills—Dactinomycin—melanoma	0.00277	0.00277	CcSEcCtD
Gadoversetamide—Urinary tract disorder—Temozolomide—melanoma	0.00276	0.00276	CcSEcCtD
Gadoversetamide—Oedema peripheral—Temozolomide—melanoma	0.00275	0.00275	CcSEcCtD
Gadoversetamide—Pruritus—Vemurafenib—melanoma	0.00275	0.00275	CcSEcCtD
Gadoversetamide—Urethral disorder—Temozolomide—melanoma	0.00274	0.00274	CcSEcCtD
Gadoversetamide—Eye disorder—Carmustine—melanoma	0.0027	0.0027	CcSEcCtD
Gadoversetamide—Hyponatraemia—Docetaxel—melanoma	0.0027	0.0027	CcSEcCtD
Gadoversetamide—Erythema—Dactinomycin—melanoma	0.00269	0.00269	CcSEcCtD
Gadoversetamide—Flushing—Carmustine—melanoma	0.00269	0.00269	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Bleomycin—melanoma	0.00268	0.00268	CcSEcCtD
Gadoversetamide—Diarrhoea—Vemurafenib—melanoma	0.00266	0.00266	CcSEcCtD
Gadoversetamide—Erythema multiforme—Temozolomide—melanoma	0.00264	0.00264	CcSEcCtD
Gadoversetamide—Eye disorder—Temozolomide—melanoma	0.00261	0.00261	CcSEcCtD
Gadoversetamide—Tinnitus—Temozolomide—melanoma	0.00261	0.00261	CcSEcCtD
Gadoversetamide—Malaise—Bleomycin—melanoma	0.0026	0.0026	CcSEcCtD
Gadoversetamide—Cardiac disorder—Temozolomide—melanoma	0.00259	0.00259	CcSEcCtD
Gadoversetamide—Flushing—Temozolomide—melanoma	0.00259	0.00259	CcSEcCtD
Gadoversetamide—Arrhythmia—Carmustine—melanoma	0.00258	0.00258	CcSEcCtD
Gadoversetamide—Dizziness—Vemurafenib—melanoma	0.00257	0.00257	CcSEcCtD
Gadoversetamide—Angiopathy—Temozolomide—melanoma	0.00254	0.00254	CcSEcCtD
Gadoversetamide—Mental disorder—Carmustine—melanoma	0.00253	0.00253	CcSEcCtD
Gadoversetamide—Immune system disorder—Temozolomide—melanoma	0.00253	0.00253	CcSEcCtD
Gadoversetamide—Mediastinal disorder—Temozolomide—melanoma	0.00252	0.00252	CcSEcCtD
Gadoversetamide—Malnutrition—Carmustine—melanoma	0.00252	0.00252	CcSEcCtD
Gadoversetamide—Erythema—Carmustine—melanoma	0.00252	0.00252	CcSEcCtD
Gadoversetamide—Cough—Bleomycin—melanoma	0.00252	0.00252	CcSEcCtD
Gadoversetamide—Chills—Temozolomide—melanoma	0.00251	0.00251	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Dactinomycin—melanoma	0.0025	0.0025	CcSEcCtD
Gadoversetamide—Vomiting—Vemurafenib—melanoma	0.00247	0.00247	CcSEcCtD
Gadoversetamide—Dry skin—Docetaxel—melanoma	0.00246	0.00246	CcSEcCtD
Gadoversetamide—Chest pain—Bleomycin—melanoma	0.00246	0.00246	CcSEcCtD
Gadoversetamide—Myalgia—Bleomycin—melanoma	0.00246	0.00246	CcSEcCtD
Gadoversetamide—Rash—Vemurafenib—melanoma	0.00245	0.00245	CcSEcCtD
Gadoversetamide—Mental disorder—Temozolomide—melanoma	0.00245	0.00245	CcSEcCtD
Gadoversetamide—Dermatitis—Vemurafenib—melanoma	0.00245	0.00245	CcSEcCtD
Gadoversetamide—Back pain—Carmustine—melanoma	0.00244	0.00244	CcSEcCtD
Gadoversetamide—Headache—Vemurafenib—melanoma	0.00243	0.00243	CcSEcCtD
Gadoversetamide—Erythema—Temozolomide—melanoma	0.00243	0.00243	CcSEcCtD
Gadoversetamide—Malnutrition—Temozolomide—melanoma	0.00243	0.00243	CcSEcCtD
Gadoversetamide—Discomfort—Bleomycin—melanoma	0.00243	0.00243	CcSEcCtD
Gadoversetamide—Malaise—Dactinomycin—melanoma	0.00243	0.00243	CcSEcCtD
Gadoversetamide—Nasopharyngitis—Docetaxel—melanoma	0.0024	0.0024	CcSEcCtD
Gadoversetamide—Dysgeusia—Temozolomide—melanoma	0.00238	0.00238	CcSEcCtD
Gadoversetamide—Confusional state—Bleomycin—melanoma	0.00237	0.00237	CcSEcCtD
Gadoversetamide—Vision blurred—Carmustine—melanoma	0.00237	0.00237	CcSEcCtD
Gadoversetamide—Alanine aminotransferase increased—Docetaxel—melanoma	0.00237	0.00237	CcSEcCtD
Gadoversetamide—Tremor—Carmustine—melanoma	0.00236	0.00236	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Bleomycin—melanoma	0.00235	0.00235	CcSEcCtD
Gadoversetamide—Oedema—Bleomycin—melanoma	0.00235	0.00235	CcSEcCtD
Gadoversetamide—Back pain—Temozolomide—melanoma	0.00235	0.00235	CcSEcCtD
Gadoversetamide—Dysphagia—Docetaxel—melanoma	0.00232	0.00232	CcSEcCtD
Gadoversetamide—Agitation—Carmustine—melanoma	0.00231	0.00231	CcSEcCtD
Gadoversetamide—Nausea—Vemurafenib—melanoma	0.00231	0.00231	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Bleomycin—melanoma	0.00231	0.00231	CcSEcCtD
Gadoversetamide—Vision blurred—Temozolomide—melanoma	0.00229	0.00229	CcSEcCtD
Gadoversetamide—Myalgia—Dactinomycin—melanoma	0.00229	0.00229	CcSEcCtD
Gadoversetamide—Bronchospasm—Docetaxel—melanoma	0.00228	0.00228	CcSEcCtD
Gadoversetamide—Tremor—Temozolomide—melanoma	0.00228	0.00228	CcSEcCtD
Gadoversetamide—Discomfort—Dactinomycin—melanoma	0.00226	0.00226	CcSEcCtD
Gadoversetamide—Ill-defined disorder—Temozolomide—melanoma	0.00226	0.00226	CcSEcCtD
Gadoversetamide—Anorexia—Bleomycin—melanoma	0.00224	0.00224	CcSEcCtD
Gadoversetamide—Agitation—Temozolomide—melanoma	0.00224	0.00224	CcSEcCtD
Gadoversetamide—Hypotension—Bleomycin—melanoma	0.0022	0.0022	CcSEcCtD
Gadoversetamide—Oedema—Dactinomycin—melanoma	0.0022	0.0022	CcSEcCtD
Gadoversetamide—Malaise—Temozolomide—melanoma	0.00219	0.00219	CcSEcCtD
Gadoversetamide—Vertigo—Temozolomide—melanoma	0.00219	0.00219	CcSEcCtD
Gadoversetamide—Convulsion—Carmustine—melanoma	0.00218	0.00218	CcSEcCtD
Gadoversetamide—Hypertension—Carmustine—melanoma	0.00217	0.00217	CcSEcCtD
Gadoversetamide—Palpitations—Temozolomide—melanoma	0.00215	0.00215	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Dactinomycin—melanoma	0.00215	0.00215	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Bleomycin—melanoma	0.00215	0.00215	CcSEcCtD
Gadoversetamide—Myalgia—Carmustine—melanoma	0.00214	0.00214	CcSEcCtD
Gadoversetamide—Chest pain—Carmustine—melanoma	0.00214	0.00214	CcSEcCtD
Gadoversetamide—Anxiety—Carmustine—melanoma	0.00214	0.00214	CcSEcCtD
Gadoversetamide—Cough—Temozolomide—melanoma	0.00212	0.00212	CcSEcCtD
Gadoversetamide—Paraesthesia—Bleomycin—melanoma	0.00211	0.00211	CcSEcCtD
Gadoversetamide—Convulsion—Temozolomide—melanoma	0.00211	0.00211	CcSEcCtD
Gadoversetamide—Hypertension—Temozolomide—melanoma	0.0021	0.0021	CcSEcCtD
Gadoversetamide—Dyspnoea—Bleomycin—melanoma	0.0021	0.0021	CcSEcCtD
Gadoversetamide—Anorexia—Dactinomycin—melanoma	0.00209	0.00209	CcSEcCtD
Gadoversetamide—Pneumonia—Docetaxel—melanoma	0.00208	0.00208	CcSEcCtD
Gadoversetamide—Confusional state—Carmustine—melanoma	0.00207	0.00207	CcSEcCtD
Gadoversetamide—Myalgia—Temozolomide—melanoma	0.00207	0.00207	CcSEcCtD
Gadoversetamide—Arthralgia—Temozolomide—melanoma	0.00207	0.00207	CcSEcCtD
Gadoversetamide—Anxiety—Temozolomide—melanoma	0.00206	0.00206	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Temozolomide—melanoma	0.00206	0.00206	CcSEcCtD
Gadoversetamide—Oedema—Carmustine—melanoma	0.00206	0.00206	CcSEcCtD
Gadoversetamide—Discomfort—Temozolomide—melanoma	0.00205	0.00205	CcSEcCtD
Gadoversetamide—Decreased appetite—Bleomycin—melanoma	0.00205	0.00205	CcSEcCtD
Gadoversetamide—Dry mouth—Temozolomide—melanoma	0.00203	0.00203	CcSEcCtD
Gadoversetamide—Pain—Bleomycin—melanoma	0.00201	0.00201	CcSEcCtD
Gadoversetamide—Conjunctivitis—Docetaxel—melanoma	0.00201	0.00201	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Carmustine—melanoma	0.00201	0.00201	CcSEcCtD
Gadoversetamide—Tachycardia—Carmustine—melanoma	0.00201	0.00201	CcSEcCtD
Gadoversetamide—Confusional state—Temozolomide—melanoma	0.002	0.002	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Dactinomycin—melanoma	0.002	0.002	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Temozolomide—melanoma	0.00199	0.00199	CcSEcCtD
Gadoversetamide—Oedema—Temozolomide—melanoma	0.00199	0.00199	CcSEcCtD
Gadoversetamide—Anorexia—Carmustine—melanoma	0.00196	0.00196	CcSEcCtD
Gadoversetamide—Epistaxis—Docetaxel—melanoma	0.00195	0.00195	CcSEcCtD
Gadoversetamide—Nervous system disorder—Temozolomide—melanoma	0.00195	0.00195	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Temozolomide—melanoma	0.00194	0.00194	CcSEcCtD
Gadoversetamide—Feeling abnormal—Bleomycin—melanoma	0.00194	0.00194	CcSEcCtD
Gadoversetamide—Skin disorder—Temozolomide—melanoma	0.00193	0.00193	CcSEcCtD
Gadoversetamide—Hypotension—Carmustine—melanoma	0.00192	0.00192	CcSEcCtD
Gadoversetamide—Hyperhidrosis—Temozolomide—melanoma	0.00192	0.00192	CcSEcCtD
Gadoversetamide—Decreased appetite—Dactinomycin—melanoma	0.00191	0.00191	CcSEcCtD
Gadoversetamide—Fatigue—Dactinomycin—melanoma	0.00189	0.00189	CcSEcCtD
Gadoversetamide—Anorexia—Temozolomide—melanoma	0.00189	0.00189	CcSEcCtD
Gadoversetamide—Pain—Dactinomycin—melanoma	0.00188	0.00188	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Carmustine—melanoma	0.00187	0.00187	CcSEcCtD
Gadoversetamide—Urticaria—Bleomycin—melanoma	0.00187	0.00187	CcSEcCtD
Gadoversetamide—Haemoglobin—Docetaxel—melanoma	0.00187	0.00187	CcSEcCtD
Gadoversetamide—Rhinitis—Docetaxel—melanoma	0.00186	0.00186	CcSEcCtD
Gadoversetamide—Body temperature increased—Bleomycin—melanoma	0.00186	0.00186	CcSEcCtD
Gadoversetamide—Haemorrhage—Docetaxel—melanoma	0.00186	0.00186	CcSEcCtD
Gadoversetamide—Insomnia—Carmustine—melanoma	0.00186	0.00186	CcSEcCtD
Gadoversetamide—Hypoaesthesia—Docetaxel—melanoma	0.00185	0.00185	CcSEcCtD
Gadoversetamide—Paraesthesia—Carmustine—melanoma	0.00185	0.00185	CcSEcCtD
Gadoversetamide—Pharyngitis—Docetaxel—melanoma	0.00185	0.00185	CcSEcCtD
Gadoversetamide—Urinary tract disorder—Docetaxel—melanoma	0.00184	0.00184	CcSEcCtD
Gadoversetamide—Dyspnoea—Carmustine—melanoma	0.00183	0.00183	CcSEcCtD
Gadoversetamide—Oedema peripheral—Docetaxel—melanoma	0.00183	0.00183	CcSEcCtD
Gadoversetamide—Somnolence—Carmustine—melanoma	0.00183	0.00183	CcSEcCtD
Gadoversetamide—Urethral disorder—Docetaxel—melanoma	0.00182	0.00182	CcSEcCtD
Gadoversetamide—Feeling abnormal—Dactinomycin—melanoma	0.00181	0.00181	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Temozolomide—melanoma	0.00181	0.00181	CcSEcCtD
Gadoversetamide—Insomnia—Temozolomide—melanoma	0.0018	0.0018	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Dactinomycin—melanoma	0.0018	0.0018	CcSEcCtD
Gadoversetamide—Decreased appetite—Carmustine—melanoma	0.00179	0.00179	CcSEcCtD
Gadoversetamide—Paraesthesia—Temozolomide—melanoma	0.00178	0.00178	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Carmustine—melanoma	0.00177	0.00177	CcSEcCtD
Gadoversetamide—Dyspnoea—Temozolomide—melanoma	0.00177	0.00177	CcSEcCtD
Gadoversetamide—Somnolence—Temozolomide—melanoma	0.00177	0.00177	CcSEcCtD
Gadoversetamide—Erythema multiforme—Docetaxel—melanoma	0.00176	0.00176	CcSEcCtD
Gadoversetamide—Pain—Carmustine—melanoma	0.00176	0.00176	CcSEcCtD
Gadoversetamide—Constipation—Carmustine—melanoma	0.00176	0.00176	CcSEcCtD
Gadoversetamide—Dyspepsia—Temozolomide—melanoma	0.00175	0.00175	CcSEcCtD
Gadoversetamide—Eye disorder—Docetaxel—melanoma	0.00174	0.00174	CcSEcCtD
Gadoversetamide—Abdominal pain—Dactinomycin—melanoma	0.00174	0.00174	CcSEcCtD
Gadoversetamide—Body temperature increased—Dactinomycin—melanoma	0.00174	0.00174	CcSEcCtD
Gadoversetamide—Hypersensitivity—Bleomycin—melanoma	0.00173	0.00173	CcSEcCtD
Gadoversetamide—Decreased appetite—Temozolomide—melanoma	0.00173	0.00173	CcSEcCtD
Gadoversetamide—Flushing—Docetaxel—melanoma	0.00173	0.00173	CcSEcCtD
Gadoversetamide—Cardiac disorder—Docetaxel—melanoma	0.00173	0.00173	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Temozolomide—melanoma	0.00171	0.00171	CcSEcCtD
Gadoversetamide—Fatigue—Temozolomide—melanoma	0.00171	0.00171	CcSEcCtD
Gadoversetamide—Pain—Temozolomide—melanoma	0.0017	0.0017	CcSEcCtD
Gadoversetamide—Constipation—Temozolomide—melanoma	0.0017	0.0017	CcSEcCtD
Gadoversetamide—Feeling abnormal—Carmustine—melanoma	0.00169	0.00169	CcSEcCtD
Gadoversetamide—Asthenia—Bleomycin—melanoma	0.00169	0.00169	CcSEcCtD
Gadoversetamide—Angiopathy—Docetaxel—melanoma	0.00169	0.00169	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Carmustine—melanoma	0.00168	0.00168	CcSEcCtD
Gadoversetamide—Immune system disorder—Docetaxel—melanoma	0.00168	0.00168	CcSEcCtD
Gadoversetamide—Mediastinal disorder—Docetaxel—melanoma	0.00168	0.00168	CcSEcCtD
Gadoversetamide—Chills—Docetaxel—melanoma	0.00167	0.00167	CcSEcCtD
Gadoversetamide—Pruritus—Bleomycin—melanoma	0.00167	0.00167	CcSEcCtD
Gadoversetamide—Arrhythmia—Docetaxel—melanoma	0.00166	0.00166	CcSEcCtD
Gadoversetamide—Feeling abnormal—Temozolomide—melanoma	0.00164	0.00164	CcSEcCtD
Gadoversetamide—Mental disorder—Docetaxel—melanoma	0.00163	0.00163	CcSEcCtD
Gadoversetamide—Abdominal pain—Carmustine—melanoma	0.00162	0.00162	CcSEcCtD
Gadoversetamide—Body temperature increased—Carmustine—melanoma	0.00162	0.00162	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Temozolomide—melanoma	0.00162	0.00162	CcSEcCtD
Gadoversetamide—Malnutrition—Docetaxel—melanoma	0.00162	0.00162	CcSEcCtD
Gadoversetamide—Erythema—Docetaxel—melanoma	0.00162	0.00162	CcSEcCtD
Gadoversetamide—Hypersensitivity—Dactinomycin—melanoma	0.00162	0.00162	CcSEcCtD
Gadoversetamide—Dysgeusia—Docetaxel—melanoma	0.00159	0.00159	CcSEcCtD
Gadoversetamide—Urticaria—Temozolomide—melanoma	0.00158	0.00158	CcSEcCtD
Gadoversetamide—Asthenia—Dactinomycin—melanoma	0.00158	0.00158	CcSEcCtD
Gadoversetamide—Abdominal pain—Temozolomide—melanoma	0.00157	0.00157	CcSEcCtD
Gadoversetamide—Body temperature increased—Temozolomide—melanoma	0.00157	0.00157	CcSEcCtD
Gadoversetamide—Back pain—Docetaxel—melanoma	0.00157	0.00157	CcSEcCtD
Gadoversetamide—Muscle spasms—Docetaxel—melanoma	0.00156	0.00156	CcSEcCtD
Gadoversetamide—Hypersensitivity—Carmustine—melanoma	0.00151	0.00151	CcSEcCtD
Gadoversetamide—Diarrhoea—Dactinomycin—melanoma	0.0015	0.0015	CcSEcCtD
Gadoversetamide—Vomiting—Bleomycin—melanoma	0.0015	0.0015	CcSEcCtD
Gadoversetamide—Rash—Bleomycin—melanoma	0.00148	0.00148	CcSEcCtD
Gadoversetamide—Dermatitis—Bleomycin—melanoma	0.00148	0.00148	CcSEcCtD
Gadoversetamide—Asthenia—Carmustine—melanoma	0.00147	0.00147	CcSEcCtD
Gadoversetamide—Hypersensitivity—Temozolomide—melanoma	0.00146	0.00146	CcSEcCtD
Gadoversetamide—Syncope—Docetaxel—melanoma	0.00145	0.00145	CcSEcCtD
Gadoversetamide—Palpitations—Docetaxel—melanoma	0.00143	0.00143	CcSEcCtD
Gadoversetamide—Asthenia—Temozolomide—melanoma	0.00143	0.00143	CcSEcCtD
Gadoversetamide—Loss of consciousness—Docetaxel—melanoma	0.00142	0.00142	CcSEcCtD
Gadoversetamide—Cough—Docetaxel—melanoma	0.00141	0.00141	CcSEcCtD
Gadoversetamide—Diarrhoea—Carmustine—melanoma	0.00141	0.00141	CcSEcCtD
Gadoversetamide—Pruritus—Temozolomide—melanoma	0.00141	0.00141	CcSEcCtD
Gadoversetamide—Convulsion—Docetaxel—melanoma	0.0014	0.0014	CcSEcCtD
Gadoversetamide—Nausea—Bleomycin—melanoma	0.0014	0.0014	CcSEcCtD
Gadoversetamide—Hypertension—Docetaxel—melanoma	0.0014	0.0014	CcSEcCtD
Gadoversetamide—Vomiting—Dactinomycin—melanoma	0.0014	0.0014	CcSEcCtD
Gadoversetamide—Rash—Dactinomycin—melanoma	0.00138	0.00138	CcSEcCtD
Gadoversetamide—Arthralgia—Docetaxel—melanoma	0.00138	0.00138	CcSEcCtD
Gadoversetamide—Chest pain—Docetaxel—melanoma	0.00138	0.00138	CcSEcCtD
Gadoversetamide—Myalgia—Docetaxel—melanoma	0.00138	0.00138	CcSEcCtD
Gadoversetamide—Unspecified disorder of skin and subcutaneous tissue—Docetaxel—melanoma	0.00137	0.00137	CcSEcCtD
Gadoversetamide—Dizziness—Carmustine—melanoma	0.00136	0.00136	CcSEcCtD
Gadoversetamide—Diarrhoea—Temozolomide—melanoma	0.00136	0.00136	CcSEcCtD
Gadoversetamide—Dry mouth—Docetaxel—melanoma	0.00135	0.00135	CcSEcCtD
Gadoversetamide—Confusional state—Docetaxel—melanoma	0.00133	0.00133	CcSEcCtD
Gadoversetamide—Oedema—Docetaxel—melanoma	0.00132	0.00132	CcSEcCtD
Gadoversetamide—Anaphylactic shock—Docetaxel—melanoma	0.00132	0.00132	CcSEcCtD
Gadoversetamide—Dizziness—Temozolomide—melanoma	0.00131	0.00131	CcSEcCtD
Gadoversetamide—Vomiting—Carmustine—melanoma	0.00131	0.00131	CcSEcCtD
Gadoversetamide—Nausea—Dactinomycin—melanoma	0.0013	0.0013	CcSEcCtD
Gadoversetamide—Shock—Docetaxel—melanoma	0.0013	0.0013	CcSEcCtD
Gadoversetamide—Rash—Carmustine—melanoma	0.0013	0.0013	CcSEcCtD
Gadoversetamide—Nervous system disorder—Docetaxel—melanoma	0.0013	0.0013	CcSEcCtD
Gadoversetamide—Dermatitis—Carmustine—melanoma	0.00129	0.00129	CcSEcCtD
Gadoversetamide—Thrombocytopenia—Docetaxel—melanoma	0.00129	0.00129	CcSEcCtD
Gadoversetamide—Tachycardia—Docetaxel—melanoma	0.00129	0.00129	CcSEcCtD
Gadoversetamide—Headache—Carmustine—melanoma	0.00129	0.00129	CcSEcCtD
Gadoversetamide—Skin disorder—Docetaxel—melanoma	0.00128	0.00128	CcSEcCtD
Gadoversetamide—Vomiting—Temozolomide—melanoma	0.00126	0.00126	CcSEcCtD
Gadoversetamide—Anorexia—Docetaxel—melanoma	0.00126	0.00126	CcSEcCtD
Gadoversetamide—Rash—Temozolomide—melanoma	0.00125	0.00125	CcSEcCtD
Gadoversetamide—Dermatitis—Temozolomide—melanoma	0.00125	0.00125	CcSEcCtD
Gadoversetamide—Headache—Temozolomide—melanoma	0.00124	0.00124	CcSEcCtD
Gadoversetamide—Hypotension—Docetaxel—melanoma	0.00123	0.00123	CcSEcCtD
Gadoversetamide—Nausea—Carmustine—melanoma	0.00122	0.00122	CcSEcCtD
Gadoversetamide—Musculoskeletal discomfort—Docetaxel—melanoma	0.0012	0.0012	CcSEcCtD
Gadoversetamide—Insomnia—Docetaxel—melanoma	0.00119	0.00119	CcSEcCtD
Gadoversetamide—Paraesthesia—Docetaxel—melanoma	0.00119	0.00119	CcSEcCtD
Gadoversetamide—Nausea—Temozolomide—melanoma	0.00118	0.00118	CcSEcCtD
Gadoversetamide—Dyspnoea—Docetaxel—melanoma	0.00118	0.00118	CcSEcCtD
Gadoversetamide—Somnolence—Docetaxel—melanoma	0.00117	0.00117	CcSEcCtD
Gadoversetamide—Dyspepsia—Docetaxel—melanoma	0.00116	0.00116	CcSEcCtD
Gadoversetamide—Decreased appetite—Docetaxel—melanoma	0.00115	0.00115	CcSEcCtD
Gadoversetamide—Gastrointestinal disorder—Docetaxel—melanoma	0.00114	0.00114	CcSEcCtD
Gadoversetamide—Fatigue—Docetaxel—melanoma	0.00114	0.00114	CcSEcCtD
Gadoversetamide—Constipation—Docetaxel—melanoma	0.00113	0.00113	CcSEcCtD
Gadoversetamide—Pain—Docetaxel—melanoma	0.00113	0.00113	CcSEcCtD
Gadoversetamide—Feeling abnormal—Docetaxel—melanoma	0.00109	0.00109	CcSEcCtD
Gadoversetamide—Gastrointestinal pain—Docetaxel—melanoma	0.00108	0.00108	CcSEcCtD
Gadoversetamide—Abdominal pain—Docetaxel—melanoma	0.00104	0.00104	CcSEcCtD
Gadoversetamide—Body temperature increased—Docetaxel—melanoma	0.00104	0.00104	CcSEcCtD
Gadoversetamide—Hypersensitivity—Docetaxel—melanoma	0.000973	0.000973	CcSEcCtD
Gadoversetamide—Asthenia—Docetaxel—melanoma	0.000948	0.000948	CcSEcCtD
Gadoversetamide—Pruritus—Docetaxel—melanoma	0.000935	0.000935	CcSEcCtD
Gadoversetamide—Diarrhoea—Docetaxel—melanoma	0.000904	0.000904	CcSEcCtD
Gadoversetamide—Dizziness—Docetaxel—melanoma	0.000874	0.000874	CcSEcCtD
Gadoversetamide—Vomiting—Docetaxel—melanoma	0.00084	0.00084	CcSEcCtD
Gadoversetamide—Rash—Docetaxel—melanoma	0.000833	0.000833	CcSEcCtD
Gadoversetamide—Dermatitis—Docetaxel—melanoma	0.000832	0.000832	CcSEcCtD
Gadoversetamide—Headache—Docetaxel—melanoma	0.000828	0.000828	CcSEcCtD
Gadoversetamide—Nausea—Docetaxel—melanoma	0.000785	0.000785	CcSEcCtD
